The usefulness of CYFRA 21-1 in diagnosing and monitoring malignant pleural mesothelioma.
Five patients with malignant pleural mesothelioma (MPM) were studied to determine whether CYFRA 21-1 is useful for diagnosis of this disease. In pleural effusions, the median concentration of CYFRA 21-1 from 4 patients with MPM was significantly higher than for 34 patients with benign diseases. The sensitivity of serum CYFRA 21-1 for diagnosis of MPM was 40% and its concentration changed in proportion to disease activity in all cases. Immunohistochemically, anticytokeratin 19 antibody revealed strong staining in both epithelial and sarcomatous MPM tissues. Based on these results, we conclude that measurement of CYFRA 21-1 in pleural effusions and serum may be useful for diagnosing and monitoring MPM.
Marukawa
M
M
Department of Internal Medicine, Kure Kyosai Hospital, Hiroshima, Japan.
Hiyama
J
J
Shiota
Y
Y
Ono
T
T
Sasaki
N
N
Taniyama
K
K
Mashiba
H
H
D000368:Aged; D000906:Antibodies / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053539:Keratin-19; D007633:Keratins / Q000276:immunology; D008297:Male; D008654:Mesothelioma / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D013902:Radiography, Thoracic
D000906:Antibodies; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins